Similar articles for PMID: 1578120

Year	Number of Results
1988	1
1989	2
1990	5
1991	21
1992	28
1993	29
1994	13
1995	5
1998	1
1999	3
2000	2
2002	1
2003	1
2013	1
2024	0

1

HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsis.

Smith CR, Straube RC, Ziegler EJ. Smith CR, et al. Infect Dis Clin North Am. 1992 Mar;6(1):253-66. Infect Dis Clin North Am. 1992. PMID: 1578120 Review.

2

Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies.

Barriere SL, Guglielmo BJ. Barriere SL, et al. Clin Pharm. 1992 Mar;11(3):223-35. Clin Pharm. 1992. PMID: 1611812 Review.

3

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

Ziegler EJ, Fisher CJ Jr, Sprung CL, Straube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, Teng NN, et al. Ziegler EJ, et al. N Engl J Med. 1991 Feb 14;324(7):429-36. doi: 10.1056/NEJM199102143240701. N Engl J Med. 1991. PMID: 1988827 Free article. Clinical Trial.

4

[Introduction of immunotherapeutic agents in clinical practice; current status concerning anti-endotoxin antibody HA-1A in the control of sepsis].

van Deventer SJ, van der Linden CJ, Roord JJ, Schellekens H, Schellekens JF. van Deventer SJ, et al. Ned Tijdschr Geneeskd. 1993 Feb 13;137(7):334-6. Ned Tijdschr Geneeskd. 1993. PMID: 8437630 Review. Dutch. No abstract available.

5

Projected impact of monoclonal anti-endotoxin antibody therapy.

Bates DW, Lee TH. Bates DW, et al. Arch Intern Med. 1994 Jun 13;154(11):1241-9. Arch Intern Med. 1994. PMID: 8203991

6

Comparison of the efficacy, safety, and therapeutic usage of HA-1A and E5 in the treatment of gram-negative sepsis.

Quintiliani R, Cooper B, Maderazo E, Nightingale C. Quintiliani R, et al. Hosp Formul. 1992 Jan;27(1):49-52, 54, 57-60. Hosp Formul. 1992. PMID: 10116116 Review.

7

Initial evaluation of a human immunoglobulin M monoclonal antibody (HA-1A) in humans.

Khazaeli MB, Wheeler R, Rogers K, Teng N, Ziegler E, Haynes A, Saleh MN, Hardin JM, Bolmer S, Cornett J, et al. Khazaeli MB, et al. J Biol Response Mod. 1990 Apr;9(2):178-84. J Biol Response Mod. 1990. PMID: 2341860

8

The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.

Gorelick KJ, Chmel H. Gorelick KJ, et al. Infect Dis Clin North Am. 1991 Dec;5(4):899-913. Infect Dis Clin North Am. 1991. PMID: 1783775 Review.

9

Monoclonal antibody therapy for gram-negative sepsis: principles, applications, and controversies.

Mehra IV, Gottlieb JE, Nash DB. Mehra IV, et al. Pharmacotherapy. 1993 Mar-Apr;13(2):128-34. Pharmacotherapy. 1993. PMID: 8469619 Review.

10

Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels.

Wortel CH, von der Möhlen MA, van Deventer SJ, Sprung CL, Jastremski M, Lubbers MJ, Smith CR, Allen IE, ten Cate JW. Wortel CH, et al. J Infect Dis. 1992 Dec;166(6):1367-74. doi: 10.1093/infdis/166.6.1367. J Infect Dis. 1992. PMID: 1431255 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year